XBiotech XBIT
NASDAQ XBIT
$2.00 -0.02 (-0.99%)
As of: Oct 21, 2026 · 9:54 AM EDT

XBiotech (XBIT) Other financing activities (2015)

Updated

Analysis

XBiotech (XBIT) Other financing activities (2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,139.37 Bn 1,107.95 Bn 19.71 Bn
2 Johnson & Johnson 618.39 Bn 536.92 Bn 17.26 Bn
3 AbbVie 508.07 Bn 481.19 Bn 12.70 Bn
4 Merck 367.07 Bn 321.44 Bn 12.21 Bn
5 Novartis Ag 298.65 Bn 262.64 Bn 11.24 Bn
6 Astrazeneca 263.08 Bn 236.77 Bn 12.86 Bn
7 Amgen 236.65 Bn 192.05 Bn 7.24 Bn
8 Gilead Sciences 192.73 Bn 166.92 Bn 6.22 Bn
9 Pfizer 171.28 Bn 117.93 Bn 10.94 Bn
10 XBiotech 60.37 Mn -475.05 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 1.04 Mn
Mar 31, 2015 -712,000.00
API Access

XBiotech Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=XBIT&period=max&api_key=YOUR_API_KEY